Samsara Bio Capital, LLC Lyra Therapeutics, Inc. Call Options Transaction History
Samsara Bio Capital, LLC
- $217 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LYRA
# of Institutions
57Shares Held
25MCall Options Held
56.6KPut Options Held
33.9K-
Perceptive Advisors LLC New York, NY12.8MShares$131 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$29.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.77MShares$18.2 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$10.9 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$10.4 Million0.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $327M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...